MedPath

A Study of the Clinical Safety, Tolerability, and Efficacy of Zoledronic Acid Compared to an Oral Bisphosphonate

Phase 3
Completed
Conditions
Osteoporosis
Registration Number
NCT00100555
Lead Sponsor
Novartis Pharmaceuticals
Brief Summary

The purpose of this trial is to study the clinical safety, tolerability, and efficacy of zoledronic acid compared to an oral bisphosphonate in postmenopausal women with osteoporosis.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
120
Inclusion Criteria
  • Postmenopausal women between 45 and 79 years of age
  • Must be osteopenic/osteoporotic
Exclusion Criteria
  • Any women of child-bearing potential

Other protocol-defined inclusion/exclusion criteria may apply.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Assess the rapidity of onset of action on bone turnover by comparing the percent change from baseline in urine N-telopeptide (NTx) in post-menopausal women
Secondary Outcome Measures
NameTimeMethod
To assess the effect on markers of bone turnover by comparing the percent change from baseline in serum C-telopeptide (CTx) and urine NTx in post-menopausal women
To assess the frequency, intensity, and "bothersomeness" of dyspepsia, as measured by the Nepean Dyspepsia Index - Short Form, Symptom Checklist
To assess patient preferences for annual i.v. therapy compared to weekly oral therapy

Trial Locations

Locations (17)

Univ. of Alabama/Division of Clinical Immunology and Rheumatology

πŸ‡ΊπŸ‡Έ

Birmingham, Alabama, United States

Radiant Research

πŸ‡ΊπŸ‡Έ

Dallas, Texas, United States

Denver Arthritis Clinic

πŸ‡ΊπŸ‡Έ

Denver, Colorado, United States

Florida Medical Research Institute

πŸ‡ΊπŸ‡Έ

Gainesville, Florida, United States

Northwestern Center for Clinical Research

πŸ‡ΊπŸ‡Έ

Chicago, Illinois, United States

The Center for Rheumatology and Bone Research

πŸ‡ΊπŸ‡Έ

Wheaton, Maryland, United States

Midwest Arthritis Center

πŸ‡ΊπŸ‡Έ

Kalamazoo, Michigan, United States

St. John's Medical Research

πŸ‡ΊπŸ‡Έ

Springfield, Missouri, United States

Deaconess Billings Clinic Research Division

πŸ‡ΊπŸ‡Έ

Billings, Montana, United States

UMDNJ-Robert Wood Johnson Medical School

πŸ‡ΊπŸ‡Έ

New Brunswick, New Jersey, United States

Scroll for more (7 remaining)
Univ. of Alabama/Division of Clinical Immunology and Rheumatology
πŸ‡ΊπŸ‡ΈBirmingham, Alabama, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.